[1]
“Design, Molecular Docking, and Pharmacokinetic Evaluation of Naproxen-Based 2‑Azetidinone Derivatives for Cancer Treatment”, AJPS, vol. 26, no. 1, pp. 22–37, Mar. 2026, doi: 10.32947/ajps.v26i1.1344.